Iodopindolol

Iodopindolol
Clinical data
Other names	[125I]Iodopindolol; 3-Iodopindolol
Identifiers
	IUPAC name (2S)-1-{[3-(125I)Iodo-1H-indol-4-yl]oxy}-3-(isopropylamino)-2-propanol;
CAS Number	76875-01-9;
ChemSpider	110369;
CompTox Dashboard (EPA)	DTXSID60998176 ;
Chemical and physical data
Formula	C14H19IN2O2
Molar mass	374.222 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)NC[C@@H](COc1cccc2c1c(c[nH]2)[125I])O;
	InChI InChI=1S/C14H19IN2O2/c1-9(2)16-6-10(18)8-19-13-5-3-4-12-14(13)11(15)7-17-12/h3-5,7,9-10,16-18H,6,8H2,1-2H3/t10-/m0/s1/i15-2; Key:LOMQONAZKMLAOB-BDIJBZSESA-N;

Iodopindolol is a beta-adrenergic selective antagonist tagged with radioactive iodine-125. It has been used to map beta receptors in cellular experiments.^[1]

References

^ Ezrailson EG, Garber AJ, Munson PJ, Swartz TL, Birnbaumer L, Entman ML (1981). "[125I]iodopindolol: a new beta adrenergic receptor probe". Journal of Cyclic Nucleotide Research. 7 (1): 13–26. PMID 6265511.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

This nuclear medicine article is a stub. You can help Wikipedia by expanding it.